Elserafy, Ahmed S.
Reda, Ashraf
Farag, Elsayed
Mostafa, Tamer
Farag, Nabil
Elbahry, Atef
Sanad, Osama
Bendary, Ahmed
Elkersh, Ahmed
Attia, Ihab
Selim, Mohammed
Khamis, Hazem
Issak, Emad R. http://orcid.org/0000-0003-4150-649X
Article History
Accepted: 17 October 2021
First Online: 15 November 2021
Declarations
:
: AstraZeneca provided assistance with publication fees for open access service. No other funding was received for this paper.
: Emad R. Issak has no conflicts of interest to declare. Ahmed S. Elserafy, Ashraf Reda, Elsayed Farag, Tamer Mostafa, Nabil Farag, Atef Elbahary, Osama Sanad, Ahmed Bendary, Ahmed Elkersh, Ihab Attiam, Mohammed Selim and Hazem Khamis have conducted scientific sessions and received honoraria from AstraZeneca, Boehringer Ingelheim, and Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: ASE: collected recommendations from the experts and wrote and revised the manuscript. ERI: literature review, medical writing, and edited and revised the manuscript. AR, EF, TM, NF, AE, OS, AB, AE, IA, MS and HK: expert opinion and revised the manuscript.